S&P 500   3,978.06 (+0.67%)
DOW   32,408.03 (+0.51%)
QQQ   307.69 (+0.56%)
AAPL   158.01 (+0.39%)
MSFT   271.58 (-0.24%)
META   200.17 (+1.19%)
GOOGL   103.80 (+2.55%)
AMZN   99.64 (+1.98%)
TSLA   193.89 (+5.81%)
NVDA   256.93 (-0.80%)
NIO   9.23 (+5.49%)
BABA   83.25 (+2.78%)
AMD   94.95 (-1.92%)
T   18.52 (+0.16%)
F   11.75 (+5.10%)
MU   58.08 (+0.76%)
CGC   1.97 (+5.91%)
GE   92.43 (+2.79%)
DIS   96.33 (+2.24%)
AMC   4.40 (+3.04%)
PFE   40.53 (-0.69%)
PYPL   75.39 (+2.98%)
NFLX   305.76 (+0.21%)
S&P 500   3,978.06 (+0.67%)
DOW   32,408.03 (+0.51%)
QQQ   307.69 (+0.56%)
AAPL   158.01 (+0.39%)
MSFT   271.58 (-0.24%)
META   200.17 (+1.19%)
GOOGL   103.80 (+2.55%)
AMZN   99.64 (+1.98%)
TSLA   193.89 (+5.81%)
NVDA   256.93 (-0.80%)
NIO   9.23 (+5.49%)
BABA   83.25 (+2.78%)
AMD   94.95 (-1.92%)
T   18.52 (+0.16%)
F   11.75 (+5.10%)
MU   58.08 (+0.76%)
CGC   1.97 (+5.91%)
GE   92.43 (+2.79%)
DIS   96.33 (+2.24%)
AMC   4.40 (+3.04%)
PFE   40.53 (-0.69%)
PYPL   75.39 (+2.98%)
NFLX   305.76 (+0.21%)
S&P 500   3,978.06 (+0.67%)
DOW   32,408.03 (+0.51%)
QQQ   307.69 (+0.56%)
AAPL   158.01 (+0.39%)
MSFT   271.58 (-0.24%)
META   200.17 (+1.19%)
GOOGL   103.80 (+2.55%)
AMZN   99.64 (+1.98%)
TSLA   193.89 (+5.81%)
NVDA   256.93 (-0.80%)
NIO   9.23 (+5.49%)
BABA   83.25 (+2.78%)
AMD   94.95 (-1.92%)
T   18.52 (+0.16%)
F   11.75 (+5.10%)
MU   58.08 (+0.76%)
CGC   1.97 (+5.91%)
GE   92.43 (+2.79%)
DIS   96.33 (+2.24%)
AMC   4.40 (+3.04%)
PFE   40.53 (-0.69%)
PYPL   75.39 (+2.98%)
NFLX   305.76 (+0.21%)
S&P 500   3,978.06 (+0.67%)
DOW   32,408.03 (+0.51%)
QQQ   307.69 (+0.56%)
AAPL   158.01 (+0.39%)
MSFT   271.58 (-0.24%)
META   200.17 (+1.19%)
GOOGL   103.80 (+2.55%)
AMZN   99.64 (+1.98%)
TSLA   193.89 (+5.81%)
NVDA   256.93 (-0.80%)
NIO   9.23 (+5.49%)
BABA   83.25 (+2.78%)
AMD   94.95 (-1.92%)
T   18.52 (+0.16%)
F   11.75 (+5.10%)
MU   58.08 (+0.76%)
CGC   1.97 (+5.91%)
GE   92.43 (+2.79%)
DIS   96.33 (+2.24%)
AMC   4.40 (+3.04%)
PFE   40.53 (-0.69%)
PYPL   75.39 (+2.98%)
NFLX   305.76 (+0.21%)
OTCMKTS:CYDY

CytoDyn - CYDY Stock Forecast, Price & News

$0.34
-0.03 (-8.09%)
(As of 03/20/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.33
$0.38
50-Day Range
$0.24
$0.42
52-Week Range
$0.15
$1.26
Volume
1.41 million shs
Average Volume
1.94 million shs
Market Capitalization
$285.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CYDY stock logo

About CytoDyn (OTCMKTS:CYDY) Stock

CytoDyn, Inc. is a clinical-stage biotechnology company, which engages in the development of innovative treatments for multiple therapeutic indications based on leronlimab. Its product include HIV, Cancer, graft-versus-host disease (GVHD), and COVID-19. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.

Receive CYDY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter.

CYDY Stock News Headlines

Stocks Positioned For The Year
This breakthrough stock has bright future this decade.
CytoDyn: There Seems To Be No Redemption
CytoDyn to Host R&D Update on Wednesday, December 7, 2022
Stocks Positioned For The Year
This breakthrough stock has bright future this decade.
Form 10-Q/A CytoDyn Inc. For: Aug 31 - StreetInsider.com
CytoDyn Inc. (CYDY)
See More Headlines
Receive CYDY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter.

CYDY Company Calendar

Last Earnings
1/09/2023
Today
3/21/2023
Fiscal Year End
5/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CYDY
Previous Symbol
NASDAQ:CYDY
CUSIP
23283M101
Fax
N/A
Employees
24
Year Founded
N/A

Profitability

Net Income
$-210,820,000.00
Pretax Margin
-82,877.34%

Debt

Sales & Book Value

Annual Sales
$270,000.00
Book Value
($0.13) per share

Miscellaneous

Free Float
828,898,000
Market Cap
$285.46 million
Optionable
Not Optionable
Beta
0.27

Key Executives

  • Cyrus Arman
    President
  • Antonio Migliarese
    CFO, Secretary, Treasurer & CAO
  • Christopher P. Recknor
    Senior Director-Research & Development
  • Michael D. Mulholland
    Senior Vice President-Finance
  • Cristina de Leon
    Head-Investor Relations













CYDY Stock - Frequently Asked Questions

How have CYDY shares performed in 2023?

CytoDyn's stock was trading at $0.2250 on January 1st, 2023. Since then, CYDY stock has increased by 51.4% and is now trading at $0.3406.
View the best growth stocks for 2023 here
.

How were CytoDyn's earnings last quarter?

CytoDyn Inc. (OTCMKTS:CYDY) announced its earnings results on Monday, January, 9th. The biotechnology company reported ($0.03) earnings per share (EPS) for the quarter.

What other stocks do shareholders of CytoDyn own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CytoDyn investors own include Inovio Pharmaceuticals (INO), Novavax (NVAX), NVIDIA (NVDA), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Vaxart (VXRT), Nokia Oyj (NOK), Pfizer (PFE), Sorrento Therapeutics (SRNE) and Moderna (MRNA).

What is CytoDyn's stock symbol?

CytoDyn trades on the OTCMKTS under the ticker symbol "CYDY."

How do I buy shares of CytoDyn?

Shares of CYDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CytoDyn's stock price today?

One share of CYDY stock can currently be purchased for approximately $0.34.

How much money does CytoDyn make?

CytoDyn (OTCMKTS:CYDY) has a market capitalization of $285.46 million and generates $270,000.00 in revenue each year.

How can I contact CytoDyn?

CytoDyn's mailing address is 1111 MAIN STREET SUITE 660, VANCOUVER WA, 98660. The official website for the company is www.cytodyn.com. The biotechnology company can be reached via phone at (360) 980-8524 or via email at mciszewski@cytodyn.com.

This page (OTCMKTS:CYDY) was last updated on 3/21/2023 by MarketBeat.com Staff